Travere Therapeutics, Inc. (TVTX)
30.22
-0.10
(-0.33%)
USD |
NASDAQ |
Feb 11, 16:00
30.24
+0.02
(+0.07%)
After-Hours: 20:00
Travere Therapeutics Market Cap : 2.704B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intuitive Surgical, Inc. | 176.19B |
| Ligand Pharmaceuticals, Inc. | 3.653B |
| Plus Therapeutics, Inc. | 37.27M |
| BioStem Technologies, Inc. | 92.21M |
| Iovance Biotherapeutics, Inc. | 1.032B |
Market Cap Related Metrics
| PS Ratio | 6.293 |
| Price to Book Value | 36.76 |
| Price | 30.22 |
| Earnings Yield | -3.59% |